SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Biogen Idec, Inc. (Massachusetts) Picks Up Neurimmune Therapeutics's Neurogenerative Programs for $32.5M Upfront With Potential for $395 Million More